Joël Ménard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joël Ménard has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Gilles Chatellier
SPIM, Faculte de Medecine Broussais Hotel Dieu, Paris, France
1 shared publication - Isabelle Colombet
SPIM, Broussais Hotel Dieu University, ERM 202, INSERM, Paris, France
1 shared publication - Laurence Leneveut
SPIM, Broussais Hotel Dieu University, ERM 202, INSERM, Paris, France
1 shared publication - Sylvain Zunino
SPIM, Broussais Hotel Dieu University, ERM 202, INSERM, Paris, France
1 shared publication - Thierry Dart
SPIM, Broussais Hotel Dieu University, ERM 202, INSERM, Paris, France
1 shared publication Véronique Daurat
Département de Recherche Clinique et de Développement, Assistance Publique, Hôpitaux de Paris, Carré historique de l’Hôpital Saint-Louis, 1, avenue Claude Vellefaux, 75010 Paris, France
1 shared publication
Latest Publications
- 30 June 2011
- Published by Elsevier in Diabetes & Metabolism
- Vol. 37 (3) , 169-175
Benfluorex: Analysis of a drug-related public health crisis
- 30 June 2011
- Published by Elsevier in Diabetes & Metabolism
- Vol. 37 (3) , 169-175
Benfluorex: Analysis of a drug-related public health crisis
- 20 May 2010
- Vol. 60 (5) , 638-43
[The on-and-off in hypertension history].
- Open Access
- 15 October 2006
- Published by EDP Sciences in médecine/sciences
- Vol. 22 (10) , 881-886
Différences et similitudes des promotions industrielles et des promotions institutionnelles
The Délégation à la Recherche Clinique d'Ile-de-France et de l'Assistance Publique/Hôpitaux de Paris (AP-HP) has elaborated a pragmatic approach for the monitoring of institutionally sponsored clinical studies. The mandatory practices aiming at preventing enrolled volunteers from risks and results from fraud and poor quality have been reviewed and a four-stage graduate monitoring has been defined, which is applied since 2002. This system needs to be scientifically assessed and adapted to the permanent evolution of national and international regulations. double dagger.
- 15 October 2006
- Published by EDP Sciences in médecine/sciences
- Vol. 22 (10) , 881-886
Open AccessDifférences et similitudes des promotions industrielles et des promotions institutionnelles
The Délégation à la Recherche Clinique d'Ile-de-France et de l'Assistance Publique/Hôpitaux de Paris (AP-HP) has elaborated a pragmatic approach for the monitoring of institutionally sponsored clinical studies. The mandatory practices aiming at preventing enrolled volunteers from risks and results from fraud and poor quality have been reviewed and a four-stage graduate monitoring has been defined, which is applied since 2002. This system needs to be scientifically assessed and adapted to the permanent evolution of national and international regulations. double dagger.
- Open Access
- 27 November 2003
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 3 (1) , 13
A computer decision aid for medical prevention: a pilot qualitative study of the Personalized Estimate of Risks (EsPeR) system
Many preventable diseases such as ischemic heart diseases and breast cancer prevail at a large scale in the general population. Computerized decision support systems are one of the solutions for improving the quality of prevention strategies. The system called EsPeR (Personalised Estimate of Risks) combines calculation of several risks with computerisation of guidelines (cardiovascular prevention, screening for breast cancer, colorectal cancer, uterine cervix cancer, and prostate cancer, diagnosis of depression and suicide risk). We present a qualitative evaluation of its ergonomics, as well as it's understanding and acceptance by a group of general practitioners. We organised four focus groups each including 6–11 general practitioners. Physicians worked on several structured clinical scenari os with the help of EsPeR, and three senior investigators leaded structured discussion sessions. The initial sessions identified several ergonomic flaws of the system that were easily corrected. Both clinical scenarios and discussion sessions identified several problems related to the insufficient comprehension (expression of risks, definition of familial history of disease), and difficulty for the physicians to accept some of the recommendations. Educational, socio-professional and organisational components (i.e. time constraints for training and use of the EsPeR system during consultation) as well as acceptance of evidence-based decision-making should be taken into account before launching computerised decision support systems, or their application in randomised trials.
- 27 November 2003
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 3 (1) , 13
Open AccessA computer decision aid for medical prevention: a pilot qualitative study of the Personalized Estimate of Risks (EsPeR) system
Many preventable diseases such as ischemic heart diseases and breast cancer prevail at a large scale in the general population. Computerized decision support systems are one of the solutions for improving the quality of prevention strategies. The system called EsPeR (Personalised Estimate of Risks) combines calculation of several risks with computerisation of guidelines (cardiovascular prevention, screening for breast cancer, colorectal cancer, uterine cervix cancer, and prostate cancer, diagnosis of depression and suicide risk). We present a qualitative evaluation of its ergonomics, as well as it's understanding and acceptance by a group of general practitioners. We organised four focus groups each including 6–11 general practitioners. Physicians worked on several structured clinical scenari os with the help of EsPeR, and three senior investigators leaded structured discussion sessions. The initial sessions identified several ergonomic flaws of the system that were easily corrected. Both clinical scenarios and discussion sessions identified several problems related to the insufficient comprehension (expression of risks, definition of familial history of disease), and difficulty for the physicians to accept some of the recommendations. Educational, socio-professional and organisational components (i.e. time constraints for training and use of the EsPeR system during consultation) as well as acceptance of evidence-based decision-making should be taken into account before launching computerised decision support systems, or their application in randomised trials.